About
At SpectroCor Ltd, we are transforming open-heart surgery with our innovative technology that uses in-the-tissue spectrometry in real time. Our device monitors myocardial oxygenation and helps the surgeons to plan and verify adequate heart protection. With about 2 million patients undergoing open-heart procedures annually, our innovation offers quality control and enhanced outcomes, offering surgeons greater precision, while the society benefits from reduced intensive care demands.
Technologies
OutlookMicrosoft Office 365WordPress.orgMobile FriendlyWordpress.comNginxCircle
Keywords
optical spectroscopyopen heart surgeryoximetryheart surgeryorgan transplantmedical sensorcardioplegiamedical devicesmedical equipment manufacturingin-tissue spectroscopyspectroscopy in cardiac carereal-time myocardial oxygen monitoringoptical tissue measurementwide spectrum tissue spectroscopyhealthcare technologyclinical decision supportregulatory compliancebiomedical engineeringintraoperative monitoringspectroscopy sensorsservicesmedical device developmentadvanced myocardial managementmedical technologycytochrome c-oxidase analysiscardiac surgery technologyspectroscopy-based medical devicereal-time intraoperative datamyocardial protectionheart tissue oxygen levels
Company Information
- Employees3
- Founded2020
Location
5 Otakaari, Espoo, Finland, 02150
